Completed NA INTERVENTIONAL 2-arm NCT01812902

Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy (LFD)

Prospective Randomized Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy

Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo

Conditions Prostate Cancer

Interventions Radical Prostatectomy

Updated 5 times since 2017 Last updated: May 8, 2018 Started: Feb 29, 2012 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01812902, this NA trial focuses on Prostate Cancer and remains completed. Sponsored by Fundação de Amparo à Pesquisa do Estado de São Paulo, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed · Phase: PHASE2 → NA
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação de Amparo à Pesquisa do Estado de São Paulo
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil